CytoPherx Obtains $34,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    401 W. Morgan Rd. Ann Arbor, MI 48108
  • Company Description
    CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funds will be used to complete U. S. clinical trials and gain FDA approval to commercialize the CytoPherx anti-inflammatory therapy for acute kidney injury.
  • M&A Terms
  • Venture Investor
    Early Stage Partners
  • Venture Investor
    ONSET Ventures
  • Venture Investor
    Capital Midwest Fund
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Emergent Medical Partners
  • Venture Investor
    Aphelion Capital
  • Venture Investor
    Lurie Investments
  • Venture Investor
    Apjohn Ventures Fund